Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
51.45
-0.28 (-0.54%)
Nov 14, 2025, 3:00 PM CST
-0.54%
Market Cap22.91B
Revenue (ttm)1.89B
Net Income (ttm)-288.68M
Shares Out445.34M
EPS (ttm)-0.64
PE Ration/a
Forward PE95.28
Dividendn/a
Ex-Dividend Daten/a
Volume2,614,151
Average Volume3,501,751
Open51.41
Previous Close51.73
Day's Range51.07 - 52.49
52-Week Range33.50 - 89.04
Beta0.88
RSI42.45
Earnings DateOct 31, 2025

About Sinocelltech Group

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research and development and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anpingxi, an antibody drug and anti-tumor product; Anjiayin for the treatment of hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and SCTV01C and SCTV01E, which are mutant strain recombinant protein vaccines. Its product pipeline includes SCT630 used for the treatment of autoimmune diseases; SCT510 for treating solid tumors; SCT-I10A, a mon... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 2,277
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.